| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |